- Home
- GDTC vs PXLW Comparison
GDTC vs PXLW Comparison
Compare GDTC & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- PXLW
- Stock Information
- Founded
- GDTC 2018
- PXLW 1997
- Country
- GDTC Singapore
- PXLW United States
- Employees
- GDTC N/A
- PXLW N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- PXLW Semiconductors
- Sector
- GDTC Health Care
- PXLW Technology
- Exchange
- GDTC Nasdaq
- PXLW Nasdaq
- Market Cap
- GDTC 28.0M
- PXLW 32.1M
- IPO Year
- GDTC 2023
- PXLW 2000
- Fundamental
- Price
- GDTC $2.04
- PXLW $0.51
- Analyst Decision
- GDTC Buy
- PXLW Strong Buy
- Analyst Count
- GDTC 1
- PXLW 2
- Target Price
- GDTC $5.00
- PXLW $1.25
- AVG Volume (30 Days)
- GDTC 9.2K
- PXLW 267.8K
- Earning Date
- GDTC 01-01-0001
- PXLW 05-13-2025
- Dividend Yield
- GDTC N/A
- PXLW N/A
- EPS Growth
- GDTC N/A
- PXLW N/A
- EPS
- GDTC N/A
- PXLW N/A
- Revenue
- GDTC $368,838.00
- PXLW $34,246,000.00
- Revenue This Year
- GDTC $5.37
- PXLW $5.21
- Revenue Next Year
- GDTC N/A
- PXLW $35.68
- P/E Ratio
- GDTC N/A
- PXLW N/A
- Revenue Growth
- GDTC N/A
- PXLW N/A
- 52 Week Low
- GDTC $1.20
- PXLW $0.46
- 52 Week High
- GDTC $4.05
- PXLW $1.18
- Technical
- Relative Strength Index (RSI)
- GDTC 38.29
- PXLW 43.50
- Support Level
- GDTC $2.00
- PXLW $0.46
- Resistance Level
- GDTC $2.45
- PXLW $0.53
- Average True Range (ATR)
- GDTC 0.12
- PXLW 0.02
- MACD
- GDTC -0.02
- PXLW 0.00
- Stochastic Oscillator
- GDTC 4.46
- PXLW 23.36
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.